vs
Side-by-side financial comparison of Atlanta Braves Holdings, Inc. (BATRA) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Atlanta Braves Holdings, Inc. is the larger business by last-quarter revenue ($61.3M vs $31.1M, roughly 2.0× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -67.6%, a 35.5% gap on every dollar of revenue. On growth, Atlanta Braves Holdings, Inc. posted the faster year-over-year revenue change (17.6% vs -4.5%). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -52.5%).
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
BATRA vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $61.3M | $31.1M |
| Net Profit | $-41.4M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -81.2% | -9.9% |
| Net Margin | -67.6% | -32.1% |
| Revenue YoY | 17.6% | -4.5% |
| Net Profit YoY | -116.7% | -52.0% |
| EPS (diluted) | $-0.64 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.3M | — | ||
| Q3 25 | $311.5M | $31.1M | ||
| Q2 25 | $312.4M | — | ||
| Q1 25 | $47.2M | $35.2M | ||
| Q4 24 | $52.1M | $32.6M | ||
| Q3 24 | $290.7M | $24.7M | ||
| Q2 24 | $282.9M | — | ||
| Q1 24 | — | $35.7M |
| Q4 25 | $-41.4M | — | ||
| Q3 25 | $30.0M | $-10.0M | ||
| Q2 25 | $29.5M | — | ||
| Q1 25 | $-41.4M | $-14.8M | ||
| Q4 24 | $-19.1M | $-6.6M | ||
| Q3 24 | $10.0M | $-16.2M | ||
| Q2 24 | $29.1M | — | ||
| Q1 24 | — | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -81.2% | — | ||
| Q3 25 | 12.5% | -9.9% | ||
| Q2 25 | 13.4% | — | ||
| Q1 25 | -94.2% | -25.7% | ||
| Q4 24 | -35.8% | -6.0% | ||
| Q3 24 | 2.2% | -46.9% | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | — | -2.5% |
| Q4 25 | -67.6% | — | ||
| Q3 25 | 9.6% | -32.1% | ||
| Q2 25 | 9.4% | — | ||
| Q1 25 | -87.7% | -42.0% | ||
| Q4 24 | -36.7% | -20.2% | ||
| Q3 24 | 3.4% | -65.7% | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | — | 43.8% |
| Q4 25 | $-0.64 | — | ||
| Q3 25 | $0.47 | $-0.29 | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $-0.66 | $-0.47 | ||
| Q4 24 | $-0.29 | $-0.25 | ||
| Q3 24 | $0.16 | $-0.53 | ||
| Q2 24 | $0.46 | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.9M | $18.9M |
| Total DebtLower is stronger | $738.6M | $136.0M |
| Stockholders' EquityBook value | $526.0M | $-10.5M |
| Total Assets | $1.6B | $235.2M |
| Debt / EquityLower = less leverage | 1.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.9M | — | ||
| Q3 25 | $82.2M | $18.9M | ||
| Q2 25 | $96.2M | — | ||
| Q1 25 | $244.7M | $5.4M | ||
| Q4 24 | $110.1M | $9.5M | ||
| Q3 24 | $100.9M | — | ||
| Q2 24 | $121.2M | — | ||
| Q1 24 | — | — |
| Q4 25 | $738.6M | — | ||
| Q3 25 | $759.9M | $136.0M | ||
| Q2 25 | $703.1M | — | ||
| Q1 25 | $699.5M | $124.9M | ||
| Q4 24 | $617.1M | $111.3M | ||
| Q3 24 | $640.1M | $106.3M | ||
| Q2 24 | $600.0M | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $526.0M | — | ||
| Q3 25 | $560.3M | $-10.5M | ||
| Q2 25 | $522.8M | — | ||
| Q1 25 | $486.1M | $2.2M | ||
| Q4 24 | $524.2M | $15.4M | ||
| Q3 24 | $530.4M | $-3.9M | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | — | $17.7M |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.7B | $235.2M | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | $237.7M | ||
| Q4 24 | $1.5B | $255.4M | ||
| Q3 24 | $1.6B | $246.8M | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | — | $246.2M |
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.44× | 56.05× | ||
| Q4 24 | 1.18× | 7.20× | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.4M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | 0.0% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.4M | — | ||
| Q3 25 | $-88.8M | $1.8M | ||
| Q2 25 | $-8.1M | — | ||
| Q1 25 | $95.8M | $1.2M | ||
| Q4 24 | $28.9M | $-6.1M | ||
| Q3 24 | $-69.0M | $-613.0K | ||
| Q2 24 | $-34.3M | — | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | $-82.3M | — | ||
| Q1 25 | $76.3M | $-4.3M | ||
| Q4 24 | $16.8M | $-8.6M | ||
| Q3 24 | $-85.5M | $-4.0M | ||
| Q2 24 | $-64.1M | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | -26.3% | — | ||
| Q1 25 | 161.5% | -12.1% | ||
| Q4 24 | 32.3% | -26.3% | ||
| Q3 24 | -29.4% | -16.3% | ||
| Q2 24 | -22.7% | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 41.3% | 15.5% | ||
| Q4 24 | 23.2% | 7.5% | ||
| Q3 24 | 5.7% | 13.9% | ||
| Q2 24 | 10.5% | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | — | ||
| Q2 25 | -0.28× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | — | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
